Related Experiment Video
Updated: Jan 7, 2026
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Prevalence and Incidence of Gastric Cancer Among Helicobacter pylori-Naïve Individuals in Japan: A Systematic Review
Chikamasa Ichita1,2, Chika Kusano3, Takuji Gotoda4
1Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan.
Background And Aim:
With Helicobacter pylori (H. pylori)-naïve adults becoming increasingly common in Japan, the magnitude of their gastric cancer (GC) risk remains uncertain and warrants clarification.
Materials And Methods:
We conducted a systematic review and meta-analysis to estimate the screen-detected prevalence and incidence of GC among H. pylori-naïve individuals in Japan. MEDLINE and EMBASE were searched for studies published between January 2014 and August 2024. Eligible studies included cross-sectional or cohort designs that confirmed H. pylori-naïve status using ≥1 validated test and reported histologically diagnosed GC. Generalized linear mixed-effects models were used to derive pooled estimates.
Results:
Of 652 screened articles, six were included (n = 248 482; four cohorts, two cross-sectional). Among these, 96 GC cases were identified. The mean age ranged from 48 to 58 years, with a male proportion between 35% and 60%. The pooled screen-detected prevalence of GC was 0.029% (95% confidence interval [CI], 0.006-0.137), equivalent to approximately one case per 3500 individuals screened. The pooled incidence from four cohorts (218 000 person-years) was 1.40 per 10 000 person-years (95% CI, 0.61-3.23), based on 30 incident cases. Pooled screen-detected prevalence of invasive GC was 0.015% (95% CI, 0.002-0.094), 80.6% of which were histologically diagnosed as gastric adenocarcinoma of the fundic gland type, an indolent subtype.
Conclusions:
The screen-detected prevalence and incidence of GC among H. pylori-naïve individuals were low. The present meta-analysis provides important baseline data to characterize GC risk among H. pylori-naïve individuals in Japan.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...